期刊文献+

非小细胞肺癌组织中Jdp2、Phf2表达变化及意义 被引量:3

Expression and significance of Jdp2 and Phf2 in non-small-cell lung cancer
下载PDF
导出
摘要 目的探讨非小细胞肺癌组织中Jun二聚化蛋白2(Jdp2)、Phf手指蛋白2(Phf2)的表达变化及意义。方法选取非小细胞肺癌患者86例,采用免疫组化法检测癌组织及正常肺组织(距肿瘤边缘>5 cm)中Jdp2、Phf2的表达,分析二者表达与非小细胞肺癌患者临床病理特征的关系,Spearman相关分析二者表达的相关性;对患者进行随访,分析Jdp2、Phf2表达与患者预后的关系。结果非小细胞肺癌组织中Jdp2、Phf2阳性表达率低于正常肺组织(P均<0.05)。非小细胞肺癌组织中Jdp2与Phf2表达呈正相关(r=0.672,P<0.05)。非小细胞肺癌组织中Jdp2、Phf2阳性表达与肿瘤TNM分期、分化程度有关(P均<0.05)。Jdp2、Phf2阳性表达患者5年生存率低于Jdp2、Phf2阴性表达患者(P<0.05)。结论非小细胞肺癌组织中Jdp2、Phf2均呈低表达,二者表达变化与肿瘤分期、分化程度及患者预后有关。 Objective To investigate the expression and significance of Jun dimerization protein 2(Jdp2)and PhD finger protein 2(Phf2)in the non-small-cell lung cancer(NSCLC)tissues.Methods Eighty-six NSCLC patients were selected.The expression levels of Jdp2 and Phf2 in the cancer tissues and adjacent normal tissues were detected by immunohistochemistry,the relationship between clinicopathological parameters was analyzed,and the correlation between the two indexes was analyzed by spearman correlation.All patients were followed up to analyze the relationship between Jdp2 and Phf2 expression and the prognosis of patients.Results The positive expression rates of Jdp2 and Phf2 in NSCLC were lower than those in the adjacent normal tissues(both P<0.05).The expression of Jdp2 and Phf2 in NSCLC tissues was positively correlated(r=0.672,P<0.05).The positive expression of Jdp2 and Phf2 in NSCLC tissues was related to the tumor TNM stage and differentiation degree(both P<0.05).The 5-year survival rate of patients with positive expression of Jdp2 and Phf2 was lower than that of patients with negative expression of Jdp2 and Phf2(P<0.05).Conclusion Jdp2 and Phf2 are low expressed in NSCLC tissues,and their expression changes are related to tumor stage,degree of differentiation,and patients’prognosis.
作者 陈蕾 邓燕 潘月影 CHEN Lei;DENG Yan;PAN Yueying(Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430030,China)
出处 《山东医药》 CAS 2020年第16期14-17,共4页 Shandong Medical Journal
基金 湖北省卫生和计划生育委员会科研项目(WJ2017M216)。
关键词 非小细胞肺癌 Jun二聚化蛋白2 Phf手指蛋白2 预后 non-small-cell lung cancer Jun dimerization protein 2 PhD finger protein 2 prognosis
  • 相关文献

参考文献6

二级参考文献91

  • 1Wei-Xia Mao,Wen Han.Correlation of contrast-enhanced CT quantitative parameters with proliferation and invasion gene expression in pancreatic cancer[J].Journal of Hainan Medical University,2017,23(21):139-142. 被引量:1
  • 2项永兵,高玉堂.非吸烟女性肺癌危险因素的多分类logistic模型分析[J].中国卫生统计,2005,22(2):66-70. 被引量:30
  • 3HENSCHKE CI, YANKELEVITZ DF, LIBBY DM, et al. Survival of patients with stage Ⅰ lung cancer detected on CT screening[J]. N Engl J Med, 2006, 355(17) :1763-1771.
  • 4LARSEN SS, VILMANN P, KRASNIK M, et al. Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: preliminary results from a randomized clinical trial[J]. Lung Cancer, 2005, 49(3) :377-385.
  • 5CRAANEN ME, COMANS EF, PAUL MA, et al. Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer[ J ]. Interact Cardiovasc Thorac Surg, 2007, 6 ( 4 ) : 433-436.
  • 6VAN ZANDWIJK N, MATHY A, BOERRIGTER L, et al. EGFR and K-RAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small cell lung cancer[J]. Ann Oncol, 2007, 18(1) : 99-103.
  • 7ONISHI H, SHIRATO H, NAGATA Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage Ⅰ non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study[ J ]. J Thorac Oncol, 2007, 2 ( 7 Suppl 3) :S94-100.
  • 8WISNIVESKY JP, BONOMI M, HENSCHKE C, et al. Radiation therapy for the treatment of unresected stage Ⅰ - Ⅱ non-small cell lung cancer [ J ]. Chest, 2005 , 128 (3) : 146! -1467.
  • 9STRAUSS G M, HERNDON J E, MADDAUS M A, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage Ⅰ b non-small cell lung cancer (NSCLC) : report of Cancer and Leukemia Group B (CALGB) Protocol 9633 [ R]. Proc ASCO, 2006,24 (18s) :365.
  • 10DOUILLARD J Y, ROSELL R, DE LENA M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage Ⅰ b-Ⅲ a non-small cell lung cancer (Adjuvant Navelbine International Trialist Association (ANITA) : a randomized controlled trial[ J ]. Lancet, 2006,7 (9) : 719-727.

共引文献83

同被引文献16

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部